Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QuicK+fire: AUT00063 in cochlear implant recipients
NCT02832128Phase 2Completed
- Sponsor
- Autifony Therapeutics
- Start
- May 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AUT00063 in hearing loss, sponsored by Autifony Therapeutics. Started May 2016; status: completed.
02
Drugs
AUT00063
03
Conditions
hearing loss
Beyond the preview
Go deeper on NCT02832128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832128.